Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
about
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Peptides as targeting probes against tumor vasculature for diagnosis and drug deliverySelecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsTargeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imagingPeptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal modelsLung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular ImagingAnti-CHMP5 single chain variable fragment antibody retrovirus infection induces programmed cell death of AML leukemic cells in vitroAnalysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescencePhage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Antibody phage display libraries: contributions to oncology.Smart polymeric nanoparticles for cancer gene delivery.Polymer micro- and nanocapsules as biological carriers with multifunctional properties.An evolved Mxe GyrA intein for enhanced production of fusion proteinsTumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo.α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer.A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies.Quantum dot-based nanoprobes for in vivo targeted imaging.A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancerRecombinant antibodies and their use in biosensors.Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy.Tapping the potential of quantum dots for personalized oncology: current status and future perspectives.Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions.Cancer active targeting by nanoparticles: a comprehensive review of literature.The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.Oligonucleotide-based theranostic nanoparticles in cancer therapy.Antibody-targeted nanoparticles for cancer treatment.Ligand-functionalization of BPEI-coated YVO4:Bi3+,Eu3+ nanophosphors for tumor-cell-targeted imaging applications.Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy.Histidine-rich stabilized polyplexes for cMet-directed tumor-targeted gene transfer.Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.Refolding of Aggregation-Prone ScFv Antibody Fragments Assisted by Hydrophobically Modified Poly(sodium acrylate) Derivatives.Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.
P2860
Q26778234-2A65A13D-A232-4D76-9A7A-47AC9B346A99Q26830028-6250B1E3-F562-49B4-A147-AC279FC96C30Q27024850-01CE7DFA-6060-4479-BE0E-DBF164CF164CQ28077999-78E8ED56-7684-4D99-8286-231C8A666E79Q28533782-2D8FD69A-DD90-4D3C-B360-AB38989F6BB7Q28538039-367DA58A-D68F-4A2E-8488-134ED7408BBEQ30851553-FC943B87-6295-4F3F-ACC1-C4DA82941910Q33567527-8EA21789-A060-4DB0-BCE1-0A1F8AE236CEQ33649756-C382512E-7C56-47F2-BE30-C1C696E12BFBQ33759991-3814C8F0-3772-4D0F-B4B7-D3BE009B1ED3Q34273411-878C7DB5-0341-47EE-9E76-BBCC0587C2FDQ34323991-A99F65B9-2199-47BD-8721-DF705E9FCE2BQ35057532-F457424A-8297-4A7F-864B-A380451995A8Q35116954-C80B157E-C591-4C03-9FD3-5C9E40A30AB2Q35121107-CD302E26-463D-4467-9066-9DDB3818D6ECQ35563975-70C97AE1-9650-460B-8977-A8C8F542D8ADQ35652276-FFBA986E-E486-4C11-A481-24F7EEB56824Q35692849-882C4199-326D-4841-AAF3-640AFF1BF7C5Q36161132-F196B4BF-1518-48AB-88D9-E85EE8E3CB26Q36250366-9E7221CA-1F45-4BE3-877E-5AA242F8523AQ37337213-A1BA0991-2B01-4A5D-9885-E55270CCD9E6Q37644883-4275ED94-DBA3-4007-8A5C-29A0C0006E38Q37967179-A8191727-1EE1-419C-854B-2667D5B637AAQ37978315-B13E76A3-BB86-474E-B48F-56A457029B75Q37990022-0CE71D72-9189-4455-A1D3-5FA5629F83EEQ38032893-E7260F5C-DFF6-4AAA-9049-0417D5CED280Q38076084-4C88498A-EC33-4029-8105-75B6377312B0Q38227494-B1D37594-EEB4-4EFE-A5F6-5BA2AA9E0DD1Q38328927-6A5BF1D9-0D25-40AE-8EBB-51CA0B080F07Q38658279-FEE3A7C9-076F-48D3-B8B7-19904291DB77Q38709499-0CA4D134-5985-43E5-874F-1F315901EC33Q38814327-6299CF56-B8D1-4C33-B87D-55D14DD3110DQ38887307-334CE924-DC9C-4E43-88F7-B0A0A583CE1FQ39119050-AA9084EE-2F11-4606-86ED-EFEA54B8517BQ39162597-1547597D-61F3-49DA-B754-ADC9A7D8593BQ42159274-D4845EC8-6E14-4ED6-95A7-7D03BE214442Q47097723-94896373-1850-48A8-82AD-08BDDD9B8FF5Q47725919-529EE95B-CF12-4218-921B-A4B5A71C0CABQ51557597-75E0353B-EB98-40AA-8591-7B828E28D7CBQ53110840-B2E12C88-0C30-451D-86D1-9C56ECFBFDC9
P2860
Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Single chain anti-c-Met antibo ...... ted imaging and drug delivery.
@ast
Single chain anti-c-Met antibo ...... ted imaging and drug delivery.
@en
type
label
Single chain anti-c-Met antibo ...... ted imaging and drug delivery.
@ast
Single chain anti-c-Met antibo ...... ted imaging and drug delivery.
@en
prefLabel
Single chain anti-c-Met antibo ...... ted imaging and drug delivery.
@ast
Single chain anti-c-Met antibo ...... ted imaging and drug delivery.
@en
P2093
P921
P1433
P1476
Single chain anti-c-Met antibo ...... ted imaging and drug delivery.
@en
P2093
Han-Chung Wu
Min-Shan Chen
Ruei-Min Lu
Yu-Ling Chang
P304
P356
10.1016/J.BIOMATERIALS.2010.12.061
P577
2011-04-01T00:00:00Z